{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:04:01Z","timestamp":1789725841294,"version":"4.0.1"},"reference-count":35,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Ocular Immunology and Inflammation"],"DOI":"10.1080\/09273948.2026.2735413","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:13:59Z","timestamp":1789722839000},"page":"1-15","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["JAK Inhibitors for Refractory Non-Infectious Ocular Inflammation: A Systematic Review and Meta-Analysis of Efficacy, Safety, and Optimal Positioning"],"prefix":"10.1080","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5051-0450","authenticated-orcid":false,"given":"\u0130. Merve","family":"U\u00e7ar Baytaro\u011flu","sequence":"first","affiliation":[{"name":"U\u015fak University","place":["U\u015fak, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1993-0403","authenticated-orcid":false,"given":"Ata","family":"Baytaro\u011flu","sequence":"additional","affiliation":[{"name":"U\u015fak University","place":["U\u015fak, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2362-7514","authenticated-orcid":false,"given":"\u015eerife Nur","family":"\u00c7iftci","sequence":"additional","affiliation":[{"name":"U\u015fak University","place":["U\u015fak, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meryem","family":"\u00dcmit Kurban","sequence":"additional","affiliation":[{"name":"U\u015fak University","place":["U\u015fak, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6822-9077","authenticated-orcid":false,"given":"Suzan","family":"Do\u011fruya","sequence":"additional","affiliation":[{"name":"U\u015fak University","place":["U\u015fak, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1908-8439","authenticated-orcid":false,"given":"G\u00fclay","family":"Alp","sequence":"additional","affiliation":[{"name":"U\u015fak University","place":["U\u015fak, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2003.06.014"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.80.9.844"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.03.057"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2013.09.048"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1509852"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2017.11.017"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1080\/09286580701585892"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-051113-024537"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2017.201"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.4103\/IJO.IJO_61_25"},{"issue":"1","key":"e_1_3_3_12_1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12348-025-00537-y","article-title":"Jak inhibitors in autoimmune ocular inflammatory diseases - a systematic review of case reports and series","volume":"15","author":"Almerri S","year":"2025","unstructured":"Almerri S, Alshatti H, Ali YT, Behbehani R. Jak inhibitors in autoimmune ocular inflammatory diseases - a systematic review of case reports and series. J Ophthalmic Inflamm Infect. 2025;15(1):93.","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/2324400"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2024.2439"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.25644"},{"key":"e_1_3_3_16_1","doi-asserted-by":"crossref","first-page":"1736522","DOI":"10.3389\/fimmu.2026.1736522","article-title":"Novel application for the jak inhibitor baricitinib in the treatment of Vogt-Koyanagi-Harada disease: a prospective cohort study","volume":"17","author":"Luo H","year":"2026","unstructured":"Luo H, Chen B, Zhang X. Novel application for the jak inhibitor baricitinib in the treatment of Vogt-Koyanagi-Harada disease: a prospective cohort study. Front Immunol. 2026;17:1736522.","journal-title":"Front Immunol"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1439338"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-026-03778-x"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/BMJ.g7647"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/BMJ.n71"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/BMJ.l6890"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1136\/BMJ.l4898"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/BMJ.i4919"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1348"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v036.i03"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-25"},{"key":"e_1_3_3_27_1","volume-title":"Brepocitinib Meets the Primary Efficacy Endpoint in the Phase 2 NEPTUNE Trial in Non-Infectious Uveitis (NCT05523765)","author":"Priovant Therapeutics","year":"2024","unstructured":"Priovant Therapeutics. Brepocitinib Meets the Primary Efficacy Endpoint in the Phase 2 NEPTUNE Trial in Non-Infectious Uveitis (NCT05523765). Company announcement; 2024. https:\/\/priovant.com\/press-release\/priovant-therapeutics-announces-positive-phase-2-neptune-study-results-for-brepocitinib-in-non-infectious-uveitis-niu-showing-strongest-efficacy-data-in-niu-observed-to-date\/."},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.01.028"},{"issue":"3","key":"e_1_3_3_29_1","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/jrsm.1053","article-title":"Gosh - a graphical display of study heterogeneity","volume":"3","author":"Olkin I","year":"2012","unstructured":"Olkin I, Dahabreh IJ, Trikalinos TA. Gosh - a graphical display of study heterogeneity. Res Synth Methods. 2012;3(3):214\u2013223.","journal-title":"Res Synth Methods"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1136\/BMJ.39489.470347.AD"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/pst.2266"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31339-3"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2017.12.039"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2017.08.019"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2109927"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-022-00767-7"}],"container-title":["Ocular Immunology and Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/09273948.2026.2735413","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/09273948.2026.2735413","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/09273948.2026.2735413","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:14:01Z","timestamp":1789722841000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/09273948.2026.2735413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":35,"alternative-id":["10.1080\/09273948.2026.2735413"],"URL":"https:\/\/doi.org\/10.1080\/09273948.2026.2735413","relation":{},"ISSN":["0927-3948","1744-5078"],"issn-type":[{"value":"0927-3948","type":"print"},{"value":"1744-5078","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ioii20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ioii20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-07-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}